Background
Shawn Michael Chalifoux was indicted in the Middle District of Florida on federal drug trafficking charges involving methamphetamine and heroin. During proceedings, his counsel raised concerns about his competency, leading to a psychological evaluation that found him incompetent due to a delusional disorder. The government moved to involuntarily administer antipsychotic medication under the framework established in Sell versus United States to restore his competency for trial.
The court’s reasoning
The court reviewed the district court’s order granting the government’s motion to administer medication. It applied the four-factor test from Sell versus United States, reviewing the first factor de novo and the remaining three for clear error. The court found that the government demonstrated an important interest in prosecuting serious drug offenses and that no special circumstances lessened that interest. Regarding the remaining factors, the court noted that expert testimony was uncontroverted, establishing that medication was necessary, would significantly further the government’s interests, and was medically appropriate. The court also rejected the defendant’s procedural objection regarding his failure to testify, noting he did not request to do so until after the magistrate judge’s report.
What it means going forward
This decision reinforces the ability of the government to seek involuntary medication for defendants found incompetent to stand trial when supported by clear and convincing evidence of medical necessity and the absence of less intrusive alternatives.